Monographie - Penicillin G sodium

Son güncelleme :
19/11/2024

Penicillin G sodium

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Benapen	Brezilya
Bencilpenicilina	Ekvador, Peru, Şili
Benpen	Avustralya, yeni Zelanda
Bensylpenicillin	İsveç
Benzapen	İran
Benzatec	Güney Afrika Cumhuriyeti
Benzatron	Brezilya
Benzylpenicillin	Danimarka, Finlandiya, İsveç, Mısır, Norveç
Benzylpenicilline	Tunus
Biconcillina	Ekvador
Crystapen	Büyük Britanya, İrlanda, Kanada
Declin	Meksika
Fortepen	Suudi Arabistan
Geepenil	Finlandiya
Natrium penicillin G	Hollanda
Novopen	Güney Afrika Cumhuriyeti
Pebencil	Venezuela
Penbendox	Meksika
Penibiot	İspanya
Penicillin	Norveç
Penicillina G sodica	Arjantin, Ekvador, Kolombiya, Portekiz, Şili
Penilevel	İspanya
Sodiopen	İspanya
Unicillina	İspanya

Kaynaklar : Penicillin G sodium

	tip	yayın
13	Dergi	Stiles ML, Allen LV. Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs. Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
440	Dergi	Stiles ML, Tu YH, Allen LV. Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs. Am J Hosp Pharm 1989 ; 46: 1408-1412.
1057	Dergi	Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072	Dergi	Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1241	Dergi	Rayani S, Jamali F. The stability of penicillin G sodium in 5% dextrose in water minibags after freezing. Can J Hosp Pharm 1985 ; 38: 162-163.
1263	Dergi	Allwood MC, Brown PW. The effect of buffering on the stability of reconstituted benzylpenicillin injection. Int J Pharm Pract 1992 ; 1: 242-244.
1725	Dergi	Oliver C, Law S. Compatibility of oxytocin, zidovudine, and penicillin G. Can J Hosp Pharm 2001 ; 54: 112-113.
2056	Dergi	Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST. Stability of benzylpenicillin during continuous home intravenous therapy. J Antimicrob Chemother 2004 ; 53: 675-677.
2087	Dergi	Ferreira E, Forest JM, Hildgen P. Compatibility of dimenhydrinate injectable by Y administration. Pharmactuel 2004 ; 37: 17-20.
2090	Dergi	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
3012	Dergi	Sullivan T, Forrest J.M, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Hosp Pharm 2015 ; 50, 3: 214-220.
3227	Dergi	Simon B, Hancu G, Gy?resi A. Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520	Laboratuar	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	Laboratuar	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3540	Laboratuar	Heparin sodium - Summary of Product Characteristics. Wockhardt 2010
3549	Laboratuar	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3580	Laboratuar	Cytarabine Accord - Résumé des caractéristiques du produit Accord Healthcare France 2016
3585	Laboratuar	Benzylpenicillin sodium - Summary of Product Characteristics Genus Pharmaceuticals 2008
3643	Laboratuar	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3648	Dergi	Hossain M.A, Friciu M, Aubin S, Leclair G. Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers. Am J Health-Syst Pharm 2014 ; 71:669-673.
3674	Laboratuar	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3702	Dergi	McDougall D.A.J, McWhinney. Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy. J Pharm Pract and Res 2014 ; 44, 1: 26-28.
3931	Laboratuar	Trimébutine (Débridat®) - Résumé des caractéristiques du produit Pfizer Laboratoire 2016
3964	Dergi	Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 2017 ; 50,1 : 27-33.
4154	Laboratuar	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4319	Dergi	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4389	Dergi	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4590	Dergi	Smith E.K, McWhinney MPhil B.C. Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service. J Pediatr Pharmacol Ther 2021 ; 51: 231-237.
4603	Dergi	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4831	Dergi	Nezvalova-Henriksen K, Huseby Holm T, Nilsson N, Kjønniksen I, Tho I. Frequently acquired drugs in neonatal intensive care and their physical compatibility. Acta Paediatr 2022 ;111:2307–2314.
4837	Dergi	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales